Pelthos Therapeutics :
PTHS
PTHS
Stock Data
$28.36
$1.09 (3.70%)
Asset Type
Common Stock
Exchange
AMEX
Currency
USD
Country
USA
Sector
HEALTHCARE
Industry
BIOTECHNOLOGY
Pelthos Therapeutics Inc., a bio-pharmaceutical company, develops and commercializes therapeutic products to help patients with unmet treatment burdens. The company is headquartered in Durham, North Carolina.
All Pelthos Therapeutics Articles
1 Article